Share the post "Thyrocare Technologies : Q1 2024 Financial Quarterly Report : YoY Sales Up 16.2 %, QoQ Up 1.7 %"
Highlights
- The presented financial data is Standalone to provide a comprehensive overview of the company performance.
- Sales over the Year and quarter: The company experienced a substantial growth of 16.2 % in the past year, substantial increase in net sales/revenue by 1.7 %.
- Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 589.13 %. Marginal increase in other income during this quarter, up by 12.81%.
- Profit over the Year and quarter: Significant improvement in profitability for Thyrocare Technologies Limited. Notable increase of 50.33 % in net profit Year to Year, Thyrocare Technologies Limited’s profitability increased by 30.79 % in this quarter.
- EPS over the Year and quarter: EPS increased by 50.32 % Year to Year. EPS increased by 30.85 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 123.61 Cr | Rs. 141.23 Cr | Rs. 143.63 Cr | + 1.7 % | + 16.2 % |
| Expenses | Rs. 90.49 Cr | Rs. 107.64 Cr | Rs. 101.28 Cr | -5.91 % | + 11.92 % |
| Operating Profit | Rs. 33.12 Cr | Rs. 33.59 Cr | Rs. 42.35 Cr | + 26.08 % | + 27.87 % |
| OPM % | 26.79 % | 23.78 % | 29.49 % | + 5.71 % | + 2.7 % |
| Other Income | Rs. 0.46 Cr | Rs. 2.81 Cr | Rs. 3.17 Cr | + 12.81 % | + 589.13 % |
| Interest | Rs. 0.8 Cr | Rs. 0.94 Cr | Rs. 0.93 Cr | -1.06 % | + 16.25 % |
| Depreciation | Rs. 8.51 Cr | Rs. 10.41 Cr | Rs. 9.45 Cr | -9.22 % | + 11.05 % |
| Profit before tax | Rs. 24.27 Cr | Rs. 25.05 Cr | Rs. 35.14 Cr | + 40.28 % | + 44.79 % |
| Tax % | 31.07 % | 23.23 % | 28.43 % | + 5.2 % | -2.64 % |
| Net Profit | Rs. 16.73 Cr | Rs. 19.23 Cr | Rs. 25.15 Cr | + 30.79 % | + 50.33 % |
| EPS in Rs | Rs. 3.16 | Rs. 3.63 | Rs. 4.74 | + 30.58 % | + 50 % |
Today, we’re looking at Thyrocare Technologies Limited’s financial performance for the Q1(Jun 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 16.2 %. However, it did see a marginal increase of 1.7 % from the previous quarter. Expenses decreased slightly by -5.91 % quarter-on-quarter, aligning with the annual rise of 11.92 %. Operating profit, while up 27.87 % compared to last year, faced a quarter-on-quarter increase of 26.08 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 2.7 %, but an expansion of 5.71 % sequentially. Other income rose by 12.81 % compared to the last quarter, despite an annual growth of 589.13 %. Interest expenses dropped significantly by -1.06 % from the previous quarter, yet the year-over-year increase remains at a moderate 16.25 %. Depreciation costs fell by -9.22 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 11.05 %. Profit before tax grew annually by 44.79 % but saw an increase from the preceding quarter by 40.28 %.
Tax expenses as a percentage of profits decreased slightly by -2.64 % compared to last year, with a more notable quarter-on-quarter increase of 5.2 %. Net profit rose by 50.33 % year-on-year but experienced a 30.79 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 50 % but a quarterly rise of 30.58 %. In summary, Thyrocare Technologies Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 123.61 Cr | Rs. 141.23 Cr | Rs. 143.63 Cr | + 1.7 % | + 16.2 % |
| Expenses | Rs. 90.49 Cr | Rs. 107.64 Cr | Rs. 101.28 Cr | -5.91 % | + 11.92 % |
| Operating Profit | Rs. 33.12 Cr | Rs. 33.59 Cr | Rs. 42.35 Cr | + 26.08 % | + 27.87 % |
| Net Profit | Rs. 16.73 Cr | Rs. 19.23 Cr | Rs. 25.15 Cr | + 30.79 % | + 50.33 % |
| EPS in Rs | Rs. 3.16 | Rs. 3.63 | Rs. 4.74 | + 30.58 % | + 50 % |
In reviewing Thyrocare Technologies Limited’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 16.2 % year-on-year growth, however, there was a minor increase of 1.7 % from the previous quarter. Expenses rose by 11.92 % compared to the previous year, with a decrease of -5.91 % quarter-on-quarter. Operating Profit surged by 27.87 % annually, and saw a 26.08 % increase from the last quarter.
Net Profit showed yearly increase of 50.33 %, and experienced a 30.79 % increase from the previous quarter. Earnings Per Share (EPS) rose by 50 % annually, however rose by 30.58 % compared to the last quarter. In essence, while Thyrocare Technologies Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
